Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of BioLife Solutions, Inc. (NasdaqCM: BLFS) to ...

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS Former Attorney General of Louisiana Charles C.

BioLife Solutions, a Bothell, Wash.-based company developing tools for cell and gene therapy, is being acquired for $1.5 billion by the life sciences corporation Repligen. BioLife is a publicly traded ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal comes two years after ...

NEW YORK, July 22, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is ...

Repligen beefs up cell therapy business with $1.5 billion deal for BioLife Repligen ‌Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at about $1.5 billion, to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Repligen gains access to cell-preservation products used in approved therapies BioLife valued at $31 per share, a 6.2% premium to last close Companies expect at least $20 million in first-year cost ...

July 22 (Reuters) - Repligen Corp said on ⁠Wednesday ⁠it would buy BioLife ⁠Solutions in a cash-and-stock deal valued at about $1.5 billion, to expand the drugmaking equipment provider's presence in ...

The Seattle Times’ Education Lab examines the educational system from early childhood through post-secondary. Education Lab is supported by Gates Foundation, Ballmer Group and The Norcliffe Foundation ...

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.